novo nordisk oral glp-1 BREAKING: The FDA has approved the first pill for obesity, marking a major milestone in the weight-loss drug market and a potential inflection point for treatment access. The daily pill Novo Nordisk launches the first

This connects you to registered healthcare providers who will be happy to discuss your treatment plan

Phase 2 data showed up to 24.2% body weight reduction at the highest dose over 48 weeks

Chen Y, Gao C, Sun Q et al (2017) MicroRNA-4639 is a regulator of DJ-1 expression and a potential early diagnostic marker for Parkinsons disease

Its important to check with each provider to make sure they serve your state before moving forward

It starts with our small-batch synthesis

An ex-vivo (made on human skin but not on real people) study examined the cocoa polyphenols and found that 0.5-0.75% of them improved skin tone and elasticity and had a similarly positive impact on GAGs (important natural moisturizing factors in the skin) and collagen synthesis than a commercial high-end moisturizer (it was an Estee Lauder one)